ZEB2 and chronic obstructive pulmonary disease: Consequently, attenuating cellular senescence and the accompanied inflammatory responses by targeting miR-200b/ZEB2 in pulmonary emphysema might represent a novel therapeutic target for COPD and/or lung inflammation.